161 related articles for article (PubMed ID: 32384514)
1. The prognostic value of ephrin type-A2 receptor and Ki-67 in renal cell carcinoma patients: An Immunohistochemical and Bioinformatical Approach; A STROBE - compliant article.
Talaat IM; Okap IS; Abou Youssif TM; Hachim IY; Hachim MY; Sheikh SME
Medicine (Baltimore); 2020 May; 99(19):e20191. PubMed ID: 32384514
[TBL] [Abstract][Full Text] [Related]
2. Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.
Herrem CJ; Tatsumi T; Olson KS; Shirai K; Finke JH; Bukowski RM; Zhou M; Richmond AL; Derweesh I; Kinch MS; Storkus WJ
Clin Cancer Res; 2005 Jan; 11(1):226-31. PubMed ID: 15671550
[TBL] [Abstract][Full Text] [Related]
3. Expression of EphA2 protein is positively associated with age, tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang L; Hu H; Tian F; Zhou W; Zhou S; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13374-80. PubMed ID: 26722543
[TBL] [Abstract][Full Text] [Related]
4. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
5. Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.
Toma MI; Erdmann K; Diezel M; Meinhardt M; Zastrow S; Fuessel S; Wirth MP; Baretton GB
PLoS One; 2014; 9(7):e102262. PubMed ID: 25025847
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Copine 1 in Patients With Renal Cell Carcinoma.
Talaat IM; Abu-Gharbieh E; Hussein A; Hachim M; Sobhy I; Eladl M; El-Huneidi W
Anticancer Res; 2022 Jan; 42(1):355-362. PubMed ID: 34969745
[TBL] [Abstract][Full Text] [Related]
8. Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.
Tatsumi T; Herrem CJ; Olson WC; Finke JH; Bukowski RM; Kinch MS; Ranieri E; Storkus WJ
Cancer Res; 2003 Aug; 63(15):4481-9. PubMed ID: 12907621
[TBL] [Abstract][Full Text] [Related]
9. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
[TBL] [Abstract][Full Text] [Related]
10. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
12. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
16. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma.
Girgis H; Masui O; White NM; Scorilas A; Rotondo F; Seivwright A; Gabril M; Filter ER; Girgis AH; Bjarnason GA; Jewett MA; Evans A; Al-Haddad S; Siu KM; Yousef GM
Mol Cancer; 2014 May; 13():101. PubMed ID: 24885701
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.
Ishizaki H; Yano H; Tsuneoka M; Ogasawara S; Akiba J; Nishida N; Kojiro S; Fukahori S; Moriya F; Matsuoka K; Kojiro M
Pathol Int; 2007 Oct; 57(10):672-80. PubMed ID: 17803656
[TBL] [Abstract][Full Text] [Related]
18. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
[TBL] [Abstract][Full Text] [Related]
20. Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.
Osman WM; Youssef NS
Int J Clin Exp Pathol; 2015; 8(7):8165-77. PubMed ID: 26339385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
